학술논문
The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target
Document Type
Article
Author
Source
In British Journal of Anaesthesia June 2019 122(6):e157-e167
Subject
Language
ISSN
0007-0912